Maribavir Sm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Takeda UK Ltd. is pleased to announce that NICE has recommended the use of LIVTENCITY? (maribavir) as a twice daily oral treatment for adult patients with post-transplant cytomegalovirus (CMV)

United kingdomCity ofRachel millerEl chaerAnthony nolanPeter wheatleyMark harberSimon meadowcroftMaribavir smDrug administrationPrnewswire takeda united kingdom ltdBritish society of bloodRegulatory agencyTakeda pharmaceutical companyNational institute for healthTakeda pharmaceutical company limited